Literature DB >> 8267175

Fentanyl or alfentanil decreases the minimum alveolar anesthetic concentration of isoflurane in surgical patients.

C L Westmoreland1, P S Sebel, A Gropper.   

Abstract

The minimum alveolar anesthetic concentration (MAC) is an accepted potency measure for inhaled anesthetics. There is no generally accepted intraoperative measure of opioid potency, partly because of the difficulty in obtaining steady state biophase concentrations. We have studied the relative potency of fentanyl and alfentanil by using computer-assisted continuous infusions (CACI), in terms of reduction of isoflurane MAC. Data are presented from 79 patients in whom anesthesia was induced with thiopental and maintained with a CACI of fentanyl (set to achieve a plasma concentration of 0, 1, 3, 6, or 8 ng/mL) or alfentanil (0, 70, 210, 400, or 1000 ng/mL) with a predetermined end-tidal concentration of isoflurane. A determination of movement in response to skin incision was made. Without any opioid, the MAC of isoflurane was 1.25%. The maximum likelihood solution to a logistic regression model showed that fentanyl 0.5 ng/mL (95% confidence intervals [CI], 0-4.6 ng/mL) or alfentanil 28.8 ng/mL (95% CI, 0-70.9 ng/mL) resulted in a 50% isoflurane MAC reduction. In the logistic regression model, age or weight were not significant factors in the model. These results suggest that the comparative intraoperative potency ratio for alfentanil and fentanyl is 58:1, and that this methodology allows for direct intraoperative comparisons of opioid potency.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8267175     DOI: 10.1213/00000539-199401000-00006

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

Review 1.  [Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics].

Authors:  S Kreuer; J Bruhn; W Wilhelm; T Bouillon
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

Review 2.  The use of ultra-short-acting opioids in paediatric anaesthesia: the role of remifentanil.

Authors:  Peter J Davis; Franklyn P Cladis
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 3.  Pharmacokinetic-pharmacodynamic relationships for opioids in balanced anaesthesia.

Authors:  H J Lemmens
Journal:  Clin Pharmacokinet       Date:  1995-10       Impact factor: 6.447

4.  An evaluation of remifentanil-sevoflurane response surface models in patients emerging from anesthesia: model improvement using effect-site sevoflurane concentrations.

Authors:  Ken B Johnson; Noah D Syroid; Dhanesh K Gupta; Sandeep C Manyam; Nathan L Pace; Cris D LaPierre; Talmage D Egan; Julia L White; Diane Tyler; Dwayne R Westenskow
Journal:  Anesth Analg       Date:  2009-10-09       Impact factor: 5.108

5.  Response surface model predictions of emergence and response to pain in the recovery room: An evaluation of patients emerging from an isoflurane and fentanyl anesthetic.

Authors:  Noah D Syroid; Ken B Johnson; Nathan L Pace; Dwayne R Westenskow; Diane Tyler; Frederike Brühschwein; Robert W Albert; Shelly Roalstad; Samuel Costy-Bennett; Talmage D Egan
Journal:  Anesth Analg       Date:  2010-08       Impact factor: 5.108

6.  [Inhalational anesthetics].

Authors:  Jan Jedlicka; Philipp Groene; Julia Linhart; Elisabeth Raith; Da Vy Mu Stapha; Peter Conzen
Journal:  Anaesthesist       Date:  2021-04       Impact factor: 1.041

7.  Effect of dexmedetomidine bolus dose on isoflurane consumption in surgical patients under general anesthesia.

Authors:  Reshma B Muniyappa; Geetha C Rajappa; Suresh Govindswamy; Prathima P Thamanna
Journal:  Anesth Essays Res       Date:  2016 Sep-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.